NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT04400474 2025-06-19CABATENGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed93 enrolled 17 charts
NCT06638931 2025-05-28ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Active not recruiting28 enrolled